The Dutch-Belgian Randomized Lung Cancer Screening Trial, known as the NELSON trial (de Koning et al), published Jan. 29 in NEJM, reconfirms that screening high-risk patients greatly reduces lung cancer deaths. Regulators and physicians should act to ensure access to these lifesaving exams.
Newswise: Latest News
Physicians and Regulators Must Act on NELSON Study published in NEJM to Support Widespread Lung Cancer Screening
July 14, 2020By
Phone services restored after widespread outages in Atlantic Canada
August 4, 2017By
Service is being restored after widespread mobile and landline phone service outages affected customers, emergency operations and airports across parts of eastern Canada.
CTVNews.ca – Top Stories – Public RSS
